Black Diamond Therapeutics BDTX Q1 2026 Earnings EPS Beat Fails to Lift Stock as Pipeline Uncertainty Lingers GAINN Q1 2026 Earnings EPS Misses Estimates by 88 Stock Unchanged IMCR Q1 2026 Earnings Surprise Profitability Defies Expectations with No Reported Revenue DUO Q2 2021 Earnings Massive EPS Miss Highlights Continued Challenges Voyager Therapeutics Inc VYGR Q1 2026 Earnings Narrowed Loss Meets Optimism in Gene Therapy Pipeline EQX Q1 2026 Earnings EPS Falls Just Short of Estimates as Gold Production Remains Steady CLPT Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Undisclosed ES Q1 2026 Earnings EPS Misses Estimates Modest Stock Reaction Nable Inc NABL Q1 2026 Earnings EPS Misses Estimates Despite Narrow Gap Stock Gains 28 AKBA Q1 2026 Earnings EPS Misses Estimates Amid Operational Developments HRMY Q1 2026 Earnings EPS Misses Estimates Stock Slips on Profitability Concerns ATNI Q1 2026 Earnings Significant EPS Miss Reflects Operational Headwinds